Wrong....PPHM personnel, in response to a question I asked Monday, indicated the exosome test in Schroit's article is under development 1)to detect and diagnose all solid tumor presence from exosomes presence in a blood serum sample, and 2) to put the test in such a form it can be sold and used commercially by end point users.
I asked Dr. W and Dr. M whether MSK was interested in exosome diagnostics. The answer was "Very" or some form of "Yes"
News 
Market Data 
Discover 
